Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

Analysts' Actions — Bank of America, Depomed, Hertz, AT&T and More


Acadia (ACAD) was upgraded to buy from neutral at Bank of America/Merrill Lynch. The valuation is more attractive, based on a $35 price target, analysts said.

Bank of America (BAC) was downgraded to hold from buy at Deutsche Bank. The valuation is less attractive, based on a $17.50 price target, Deutsche said.

CenterPoint (CNP) was downgraded to underperform from neutral at Credit Suisse. The valuation is...